iAMP® Bacterial Meningitis Panel
The iAMP® Bacterial Meningitis (BMS) Panel is an extraction-free real-time fluorescent isothermal PCR assay based on Atila’s proprietary isothermal amplification technology intended for the simultaneous qualitative detection and differentiation of nucleic acids from common pathogens and drug resistance gene markers in cerebrospinal fluid (CSF) specimens.
They include pathogens such as H. influenzae, L. monocytogenes, N. meningitidis, S. agalactiae, S. pneumoniae, E. coli, C. neoformans and drug resistance (DR) gene markers such as carbapenemase genes (NDM, KPC, OXA-48, VIM, IMP), extended spectrum beta-lactamase (ESBL) gene (CTX-M1), vancomycin resistance genes (VanA, VanB), oxacillin/methicillin resistance gene (MecA), sulfanamide resistant genes (SUL1, SUL2, SUL3), trimethoprim resistant genes (dfrA1, dfrA5, dfrA12, dfrA17), plasmid-mediated quinolone resistance marker (QnrS), and Marcolide resistant genes (MefA, MrsA, ermA, ermB, ermC, ereA, mphA).
Each kit includes 96 tests.
This product is for research use only (RUO).
iAMP® Bacterial Meningitis Panel
Bacterial meningitis is a serious, life-threatening infection of the protective membranes surrounding the brain and spinal cord. It often begins suddenly and can progress rapidly, causing symptoms such as severe headache, fever, stiff neck, nausea, confusion, and sensitivity to light. If left untreated, bacterial meningitis can lead to brain damage, hearing loss, long-term neurological complications, or death within hours to days. Because different bacteria can cause the disease and many strains are resistant to common antibiotics, quick and accurate identification of the pathogen is essential for starting the right treatment.
The iAMP® Bacterial Meningitis Panel provides a simple, extraction-free workflow and delivers accurate results in under 90 minutes. Using Atila’s proprietary real-time isothermal PCR technology, it directly detects BMS pathogens from cerebrospinal fluid. This enables clinicians to identify the exact cause of infection and tailor therapy faster than traditional methods, improving survival rates, reducing complications, and helping prevent the spread of resistant pathogens.
Features Include
Technical Specs
Workflow Overview CSF specimen.
This section is for demonstrative purposes only and may be incomplete or inaccurate. Always refer to the product instructions for precise guidelines and directions.
CSF in sample tube
Add 50 µL of 2X sample Buffer (2XSB) to 50 µL of CSF
Vortex briefly (2-3s) & incubate at 95°C for 10 minutes.
Add 10µL sample into Zebra BioDome tubes.
Run on standard PCR instrument.
